Akura Medical
PrivateLast Round
Series C
Dec 1, 2025
Est. Valuation
$215M
Total Funding Raised
$115M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Akura Medical operates in Healthcare & Life Sciences and is based in Los Gatos, California. Its latest recorded funding round was a Series C round in December 2025.
Akura Medical is a medical technology company that develops mechanical thrombectomy systems and integrated imaging software to treat venous thromboembolism.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akura Medical Comparables
Compare Akura Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inquis Medical | 89% | |
| Inari Medical, Inc. | 87% | |
| Thrombolex, Inc. | 86% |
For institutional investors. Book with your work email.
Akura Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 1, 2025 | ||||
| Series B | Oct 3, 2023 | ||||
| Series A Extension | Jan 10, 2022 |
For institutional investors. Book with your work email.
Akura Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shifamed | Series B, Series A Extension, Seed |
| Cormorant Asset Management | Series C, Series B, Series A Extension |
| Unorthodox Ventures | Series B, Series C |
| The Capital Partnership | Series A Extension, Series C, Series B |
| PA MedTech VC Fund | Series B, Series A Extension, Series C |
| Lilly Asia Ventures | Series B, Series C |
| Lilly Asia Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
Raised $53M led by Qatar Investment Authority.
For institutional investors. Book with your work email.
Akura Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Akura Medical's valuation, stock price, and market status.
Is Akura Medical a public or private company?
Akura Medical is a private company.
What is the current stock price of Akura Medical?
Akura Medical is a private company, so its shares have no public market price. Caplight tracks Akura Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Akura Medical worth (valuation)?
Akura Medical's valuation is estimated at $215.0M based on funding round data.
Can I buy Akura Medical stock?
Akura Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Akura Medical's last funding round?
Akura Medical's most recent funding round was Series C on December 1, 2025.
Who are the main investors in Akura Medical?
Key investors in Akura Medical include Cormorant Asset Management, The Capital Partnership, Cormorant Asset Management, Qatar Investment Authority.
Will Akura Medical IPO soon?
No public IPO plans have been announced for Akura Medical.
How can I track Akura Medical secondary market activity?
Caplight tracks bids, offers, and trades in Akura Medical's shares on secondary markets.